WATSON 405
Pill imprint WATSON 405 has been identified as Lisinopril 2.5 mg.
Lisinopril is used in the treatment of high blood pressure; heart failure; heart attack; diabetic kidney disease; migraine prevention (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy.
Lisinopril 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Lisinopril Images
- Imprint:
-
WATSON
405 - Strength:
- 2.5 mg
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
dibasic calcium phosphate
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
pregelatinized starch
corn starch
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0405
Advertisement
More Lisinopril resources
- Lisinopril
- Lisinopril (Wolters Kluwer)
- lisinopril (Cerner Multum)
- lisinopril (Micromedex) - Includes Dosage Information
- Lisinopril (AHFS DI)
- Lisinopril (FDA)
- Lisinopril (Wolters Kluwer)
Search Again
